first MIGS device-the i Stent®-in the United States, followed by our next-generation i Stent inject® device in September 2018. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus.
And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and medical therapies for glaucoma, corneal health, and retinal diseases. Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol " GKOS" Our global headquarters is located in Aliso Viejo, California
with additional locations in San Clemente, California and Burlington, Massachusetts. How will you make an impact? The Senior RBM is responsible for training and helping to integrate the i Stent technology into their assigned practice.
You will achieve quarterly sales objectives by selling to targeted ophthalmic surgeons within the assigned territory. The Senior RBM will attend surgeries and help the surgeon to achieve the desired surgical outcomes for the patient. The Senior RBM will achieve these standards by focusing on the customer while managing the territory for the best return on investment. What will you do? Prospecting by initiating sales calls to sell the surgeon on the Glaukos
i Stent and initiate surgical wet-labs to train the surgeon.
Attend the initial i Stent surgeries until the surgeon is confident and skilled to perform the cases. Attend surgeries as needed to update on new techniques to improve surgical outcomes. Train the office staff and the doctor to recognize and convert patients to the i Stent technology using Glaukos Practice System (GPS). Work with the surgeon and staff to educate and assist in getting proper reimbursement for the Glaukos i Stent. Attend targeted meetings as directed to increase sales lead opportunities and protect existing business. How will you get here? Education: Bachelor's degree required.
Concentration in Business or Marketing preferred. Requirements: 3 plus years of ophthalmic medical sales experience (either surgical or medical). The preferred candidate would have both ophthalmic surgical and medical experience. Experience developing and expanding new territories. Proven experience meeting and exceeding targeted goals. Ability to build relationships and interact with all levels. Ability to communicate with KOLs and surgeons both in the OR and outside. Proven ability to build and retain customer base. Experience with tracking CRM software. Ability to work within a budget.
Ability to comply with procedures and processes. Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. These are just a few of the terms our employees use to describe their experiences as a part of the Glaukos family. Those may seem like big aspirations, but here at Glaukos, we recognize the deep significance and profound meaning that comes from knowing that we can make a meaningful difference by helping improve eyesight of people worldwide. And because we're a rapidly growing company with a dynamic, fast-paced culture, individual employees are empowered with more diverse and enriching challenges that might not be possible at a larger company, and more fulfillment in knowing every person and every task is directly tied to making a difference in the life of others.
We offer competitive salary (based on experience), bonus eligibility, medical/dental/vision, life insurance, stock options, 401(k) Employer Match, Employee Stock Purchase Program, generous time off & paid holidays as well as time-off to volunteer in the community, plus the opportunity to work for a company that is pioneering a new glaucoma treatment class! Moreover, Glaukos Corporation has been Certified as a Great Place to Work consecutively over the last three years!
Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, interaction including interactionual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. ABOUT US Founded in 1998, Glaukos Corporation is an ophthalmic medical technology and medical company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.
Our company was the first company to bring to market Micro-Invasive Glaucoma Surgery (MIGS), the micro-invasive procedure which revolutionized the treatment and management of glaucoma. In 2012, we launched our first MIGS device-the i Stent®-in the United States, followed by our next-generation i Stent inject® device in September 2018 and i Stent inject® W in September 2020. In November 2019, Glaukos acquired Avedro, maker of the first and only FDA-approved cross-linking technology for progressive keratoconus. And we continue to seek to leverage our platform technologies to build a comprehensive and proprietary portfolio of micro-scale surgical and medical therapies for glaucoma, corneal health, and retinal diseases.
Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol " GKOS" Our global headquarters is located in San Clemente, California with additional locations in Waltham and Burlington, Massachusetts. Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employmentwithout regard to race, color, religion, interaction including interactionual orientation and genderidentity, national origin, disability, protected Veteran Status, or any othercharacteristic protected by applicable federal, state, or local law.
